Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Biologics, Free Full-Text

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights - ScienceDirect

Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment

Antiviral activity of medicinal plant-derived products against SARS-CoV-2 - Jonatas Rafael de Oliveira, Beatriz Sales Antunes, Gabriela Oliveira do Nascimento, Jaqueline Cadorini de Souza Kawall, João Victor Bianco Oliveira, Kevin Gustavo dos

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

Researchers evaluate artemisinin for COVID-19 management

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules